- Q1 2024 Celcuity Inc Earnings Call TranscriptMay 15, 2024$17.23 (+2.01%)Earnings
- Q4 2023 Celcuity Inc Earnings Call TranscriptMar 27, 2024$18.16 (+3.65%)Earnings
- Q3 2023 Celcuity Inc Earnings Call TranscriptNov 13, 2023$10.89 (+1.11%)Earnings
- Celcuity Inc Science Day (Virtual) TranscriptSep 21, 2023
- Q2 2023 Celcuity Inc Earnings Call TranscriptAug 10, 2023$10 (+0.10%)Earnings
- Q1 2023 Celcuity Inc Earnings Call TranscriptMay 15, 2023$9.58 (-0.73%)Earnings
- Celcuity Inc at Needham Healthcare Conference (Virtual) TranscriptApr 19, 2023
- Q4 2022 Celcuity Inc Earnings Call TranscriptMar 23, 2023$10.06 (+0.50%)Earnings
- Q3 2022 Celcuity Inc Earnings Call TranscriptNov 10, 2022$10 (-0.50%)Earnings
- Q2 2022 Celcuity Inc Earnings Call TranscriptAug 11, 2022$10.64 (+1.33%)Earnings
- Q1 2022 Celcuity Inc Earnings Call TranscriptMay 16, 2022$5.66 (+5.79%)Earnings
- Celcuity Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- Celcuity Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
- Q4 2021 Celcuity Inc Earnings Call TranscriptMar 23, 2022$8.04 (-1.83%)Earnings
- Q3 2021 Celcuity Inc Earnings Call TranscriptNov 08, 2021$18.85 (-0.48%)Earnings
- Q2 2021 Celcuity Inc Earnings Call TranscriptAug 09, 2021$20.57 (-1.34%)Earnings
- Q1 2021 Celcuity Inc Earnings Call TranscriptMay 10, 2021$25.17 (-7.26%)Earnings
- Celcuity Inc Announces Worldwide Licensing Agreement with Pfizer - Corporate Call TranscriptApr 08, 2021
- Q4 2020 Celcuity Inc Earnings Call TranscriptFeb 16, 2021$16.46 (-0.66%)Earnings
- Q3 2020 Celcuity Inc Earnings Call TranscriptNov 09, 2020$5.8 (+1.93%)Earnings
- Q2 2020 Celcuity Inc Earnings Call TranscriptAug 10, 2020$6.14 (-0.81%)Earnings
- Q1 2020 Celcuity Inc Earnings Call TranscriptMay 07, 2020$5.51 (-5.00%)Earnings
- Q4 2019 Celcuity Inc Earnings Call TranscriptMar 12, 2020$6.73 (-5.48%)Earnings
- Q3 2019 Celcuity Inc Earnings Call TranscriptNov 07, 2019$14.04 (-0.43%)Earnings
- Q2 2019 Celcuity Inc Earnings Call TranscriptAug 08, 2019$19.8 (-0.85%)Earnings
- Q1 2019 Celcuity Inc Earnings Call TranscriptMay 07, 2019$21.8 (-1.80%)Earnings
- Q4 2018 Celcuity Inc Earnings Call TranscriptFeb 26, 2019$23.31 (-3.08%)Earnings
Celcuity Inc Announces Worldwide Licensing Agreement with Pfizer - Corporate Call Transcript
Greetings. Welcome to the Celcuity-Pfizer License Agreement Conference. (Operator Instructions)
Please note, this conference is being recorded. I will now turn the conference over to your host, Brian Sullivan, Chief Executive Officer and Co-Founder of Celcuity. Thank you. You may begin.
Good afternoon, everyone. Thank you for attending this call. We have quite a news to report. We issued 2 press releases today, one announcing a global license agreement with Pfizer for a small molecule inhibitor, gedatolisib; the second press release we issued provides additional details about results from a Phase Ib trial, details about our team and updates on debt financing that we closed today as well.
So turning to Page 2 of the presentation, if you're on the webcast. I'd first start off with the background about the rationale and how we arrived at the decision and ultimately, to license gedatolisib. I'd like to provide an overview of gedatolisib's mechanism and its advantages relative to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)